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Neurobiology of Disease
Pharmacological and Genetic Reversal of Age-Dependent
Cognitive Deficits Attributable to Decreased presenilin
Function
SeanM. J. McBride,1,2* Catherine H. Choi,1,2,3* Brian P. Schoenfeld,1,2* Aaron J. Bell,1,2David A. Liebelt,1,2
David Ferreiro,1,2 Richard J. Choi,1,2 Paul Hinchey,1,2Maria Kollaros,1,2 Allison M. Terlizzi,1,2Neal J. Ferrick,1,2
Eric Koenigsberg,1,2 Rebecca L. Rudominer,1,2 Ai Sumida,4 Stephanie Chiorean,4 Kathleen K. Siwicki,5
Hanh T. Nguyen,1,2Mark E. Fortini,6 Thomas V. McDonald,1,2† and Thomas A. Jongens4†
1Section of Molecular Cardiology and 2Departments of Medicine and Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York
10461, 3Department of Dermatology, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102, 4Department of Genetics, University of
Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, 5Department of Biology, Swarthmore College, Swarthmore, Pennsylvania 19081,
and 6Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107
Alzheimer’s disease (AD) is the leading cause of cognitive loss and neurodegeneration in the developed world. Although its genetic and
environmental causes are not generally known, familial forms of the disease (FAD) are attributable to mutations in a single copy of the
Presenilin (PS) and amyloid precursor protein genes. The dominant inheritance pattern of FAD indicates that it may be attributable to
gain or change of function mutations. Studies of FAD-linked forms of presenilin ( psn) in model organisms, however, indicate that they
are loss of function, leading to the possibility that a reduction in PS activity might contribute to FAD and that proper psn levels are
important for maintaining normal cognition throughout life. To explore this issue further, we have tested the effect of reducing psn
activity during aging in Drosophila melanogastermales. We have found that flies in which the dosage of psn function is reduced by 50%
display age-onset impairments in learning and memory. Treatment with metabotropic glutamate receptor (mGluR) antagonists or
lithium during the aging process prevented the onset of these deficits, and treatment of aged flies reversed the age-dependent deficits.
Genetic reduction of Drosophilametabotropic glutamate receptor (DmGluRA), the inositol trisphosphate receptor (InsP3R), or inositol
polyphosphate 1-phosphatase also prevented these age-onset cognitive deficits. These findings suggest that reduced psn activity may
contribute to the age-onset cognitive loss observed with FAD. They also indicate that enhanced mGluR signaling and calcium release
regulated by InsP3R as underlying causes of the age-dependent cognitive phenotypes observed when psn activity is reduced.
Introduction
Alzheimer’s disease (AD) is a neurodegenerative disease charac-
terized by progressive impairments in memory and cognitive
abilities with a typical late age onset, although in cases of early
onset familial Alzheimer’s disease (FAD), the onset can be as early
as the third decade of life. The histopathological hallmarks of AD
are amyloid plaques and neurofibrillary tangles in the brains of
afflicted patients (Alzheimer, 1907; Selkoe, 2002; Mattson, 2004;
Hardy, 2006; Small andGandy, 2006). Themajority of FAD cases
are linked to mutations in the Presenilin 1 and Presenilin 2 (PS1/
PS2) genes, with additional cases linked tomutations in the amy-
loid precursor protein (APP) gene. FAD cases exhibit dominant
inheritance pattern in which the disease is caused by a mutation
in a single copy of one of these three genes (Mattson, 2004; Shen
and Kelleher, 2007).
In humans as well as in animal and cell culture models of AD,
FAD-linked PS and APPmutations generally, although not in all
cases, result in an enhanced ratio of -amyloid 1-42 (A1-42) to
A1-40 (Moehlmann et al., 2002; Schroeter et al., 2003; Qi-
Takahara et al., 2005; Walker et al., 2005; Kumar-Singh et al.,
2006; Sambamurti et al., 2006; De Strooper, 2007; Isoo et al.,
2007; Shen and Kelleher, 2007; Shioi et al., 2007). This finding
and the dominant inheritance pattern of FAD has led to a model
suggesting that FAD-linked mutations in PS1, PS2, and APP lead
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to gain-of-function or change-of-function forms of PS or APP
protein (Hardy, 2006; Small and Gandy, 2006).
Studies in mice, Drosophila, and Caenorhabditis elegans indi-
cate that FAD-linked presenilinmutations have reduced function
with respect to cleavage substrates (De Strooper, 2007; Shen and
Kelleher, 2007). Both loss-of-function mutations in presenilin
( psn) and FAD-linked mutations lead to an increase in GSK-3
activity, which is normally negatively regulated by presenilin and
may be a -secretase-independent function (Baki et al., 2004;
Serban et al., 2005; Shioi et al., 2007). Finally, the high number of
different mutations in presenilin that give rise to FAD is more con-
sistent with a loss-of-function mechanism as gain-of-function or
change-of-functionmutations for aproteinarenormally considered
to be rare, particularly because the mutations in presenilin 1 are
spread throughout different portions of the protein (Saura et al.,
2004; De Strooper, 2007; Shen and Kelleher, 2007). Together, these
results suggest the possibility that a reduction in the functional ac-
tivity of PS1 and PS2 contribute to the pathogenesis of FAD, includ-
ing cognitive loss.
We investigate the effect of reducing psn function on cogni-
tion during aging as an approach to determine whether lowered
psn function(butnotcompletelyabsent function)maycontribute to
cognitive impairment. We find that reduction in psn function leads
to age-onset cognitive deficits. Through pharmacological and ge-
netic studies, we identify misregulation of metabotropic glutamate
receptor (mGluR) signaling and inositol trisphosphate receptor
(InsP3R)-mediated calcium release, as causal for the observed age-
onset cognitive dysfunction. The implications of these studies to-
ward understanding and possibly treating certain aspects of AD are
discussed.
Materials andMethods
Drosophila strains and drug testing. Drosophila strains used in this study
are described in supplemental Table 1 (available at www.jneurosci.org as
supplemental material). The Drosophila strains were cultured as in the
study by McBride et al. (2005). Drugs were obtained from Tocris Cook-
son and solubilized according to the instructions of the manufacturer.
They were added to the fly food after cooling to the appropriate concen-
tration. Concentrations used were based on dose–response testing per-
formed in a previous study on theDrosophila fragile Xmental retardation
gene dfmr1 mutants (McBride et al., 2005). Vehicle for each drug was
added to the appropriate control food for each experiment.
Behavioral training and testing. Virgin male flies were collected under
ether anesthesia within 4 h of eclosion. Virgin XX, yf females were col-
lected on the day of eclosion and kept in food vials in groups of 10–15.
Flies were aged in a 12 h light/dark cycle before behavioral training and
testing. All testing was performed during the relative light phase. Mated
females were 5 d old and observed to mate with a male the night before
training. The virgin females that were used as targets were 4 d old. All
male subjects were transferred to fresh control food the day before test-
ing. Male flies were assigned to random groups for behavior training and
testing, which was performed blind (Siegel and Hall, 1979; Kane et al.,
1997;McBride et al., 1999). The total amount of time amale was engaged
in courtship activity while paired with an unanesthetized target female
during a test period of 10min or until successful copulation occurredwas
scored. A courtship index (CI) was calculated as the percentage of total
observation time spent courting (Siegel andHall, 1979). Binning of naive
courtship behavior was performed as in the study by McBride et al.
(2005), except that the percentage of flies advancing to a particular stage
of courtship during the courtship interval was scored and compiled.
Locomotor testing was done as in the study by McBride et al. (2005).
Cell death and mushroom body morphological analysis. Terminal de-
oxynucleotidyl transferase-mediated biotinylated UTP nick end labeling
(TUNEL) assays were performed according to Ye and Fortini (1999)
using a S7110 kit fromOncor. Brains were treated following the protocol
for imaginal discs. Acridine Orange stainings were performed according
to He´riche´ et al. (2003). Analysis of stained brains was performed by
three-dimensional reconstruction of optic stacks taken at 0.5musing a
Leica scanning confocal microscope. The number of cell death foci and
their relative position were tabulated for each genotype. Analysis of
mushroom body (MB) morphology was performed as described by
McBride et al. (2005).
Statistical analyses. CIs of tested males were subjected to arcsin square
root transformations to approximate normal distributions (Joiner and
Griffith, 1997; McBride et al., 1999). ANOVAs were performed on pair-
wise comparisons of arcsin transformed data to get critical p values. All
statistics were performed using Statview 3.0.
Results
Examination of the effect of decreased presenilin activity
during aging
Drosophila has a single psn gene ortholog, the protein sequence of
which is50% identical to human PS1 and PS2 (Boulianne et al.,
1997; Hong and Koo, 1997). The encoded presenilin protein is
expressed in a wide range of tissues, including the brain (Ye and
Fortini, 1998). Isolation and characterization of several loss-of-
function mutants have revealed that psn is an essential gene, re-
quired for proper neurogenesis andNotch processing (Struhl and
Greenwald, 1999; Ye et al., 1999). Biochemical studies of the
Drosophila presenilin protein have shown that it is a component
of the -secretase complex like its mammalian counterparts (De
Strooper, 2003; Hu and Fortini, 2003; Takasugi et al., 2003).
The underlying nature of the mutations in PS1 and PS2 that
give rise to FAD are unclear (Saura et al., 2004;Qi-Takahara et al.,
2005; Walker et al., 2005; Kumar-Singh et al., 2006; Sambamurti
et al., 2006; De Strooper, 2007; Hardy, 2007; Isoo et al., 2007;
Shen and Kelleher, 2007; Wolfe, 2007). However, studies in
model organisms indicate that the FAD-linked mutations may
result in a reduction of PS1 and PS2 activity (De Strooper, 2007;
Shen andKelleher, 2007). This possibility suggests that somephe-
notypes associated with Alzheimer’s disease, including age-onset
cognitive loss, may be attributable to a reduction in overall PS
activity levels. To investigate this possibility further, we tested the
effect of reducing psn activity using known psn loss-of-function
alleles. We evaluated the learning and memory capabilities of
young adult flies heterozygous for a given psnmutant allele (here-
after referred to as “psn-het flies”), with only 50% of the psn
found in wild-type (WT) control flies [the wild-type control
strain isOregon-R (OreR), the background strain fromwhich the
psn alleles we used in this study were derived)]. We then reeval-
uated their capabilities at an older age to determine whether any
age-related cognitive decline could be observed. We took advan-
tage of the large number of psn alleles with diminished function
that have been obtained from several genetic screens. In total, 10
different loss-of-function alleles of psn were examined, to ensure
that any observed effects were not attributable to second site
mutations or other background effects and crossed each to our
WT OreR line (for a description of the alleles used, see Materials
and Methods and Supplemental Table 1, available at www.
jneurosci.org as supplemental material).
Examining naive courtship, learning, andmemory in aged
control flies
Before embarking on an examination of the effects of aging on
psn-het flies, using the courtship based assays, we first needed to
establish a timeline in which courtship-based learning andmem-
orywere not affected in our controlOreR (WT) flies. The effect of
aging on naive courtship and courtship conditioned learning and
memory has not been extensively characterized. The lifespan of
Drosophila is 60 d (after eclosion, in adult form); therefore, a
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5-d-old adult fly is relatively “young,” a 30-d-old fly is “moder-
ately aged,” and a 45-d-old fly is relatively “old.”
Courting Drosophilamales perform a characteristic sequence
of behaviors when paired with a female: orienting toward and
following the female, tapping her with his forelegs, vibrating one
wing, licking her genitalia, and attempting to copulate (Hall,
1994). The percentage of time themale spends performing any of
these behaviors toward a target during a defined period of time is
referred to as the CI (Siegel and Hall, 1979). We tested progres-
sively older naive males and found that 45-d-old WT flies per-
form naive courtship as robustly as young 5-d-old flies (Fig. 1A).
This indicates that there are no sensory impairmentswith age that
diminish courtship. Furthermore, the quality of this courtship
was not different between 5- and 45-d-oldWT flies (supplemen-
tal Fig. S1, available at www.jneurosci.org as supplemental mate-
rial), nor was the level of locomotor activity (supplemental Fig.
S2, available at www.jneurosci.org as supplemental material).
We next determined an age range within which learning and
memory would be intact in WT flies. Learning and memory can
be examined in Drosophila by assaying conditioned courtship
behavior. In conditioned courtship, a male fly learns to modify
his courtship behavior after experience with an unreceptive fe-
male (Siegel and Hall, 1979; Hall, 1994). Virgin females generally
respond to a courting male by mating. However, recently mated
females are unreceptive and have an overlapping but altered
pheromonal profile that naive males find less provocative than
that of virgin female targets (Ejima et al., 2007). A naive male
paired with a mated female will initially court her, but his court-
ship activity soon decreases. When this learning during training
(LDT) is quantified, by comparing the CI during the first 10 min
with a mated female to the CI of the last 10 min period of a 1 h
pairing, wild-type flies typically show a40% decrease in court-
ship activity (Joiner and Griffith, 1997; Kane et al., 1997). Hence,
LDT is a form of behavioral plasticity but is distinct and separate
from courtship suppression assayed after training, which is a
form of associative memory (Tompkins et al., 1983; Ackerman
and Siegel, 1986).When amale is pairedwith a virgin female after
1 h of experience with a mated female, his courtship remains
depressed for 2–3 h (Siegel and Hall, 1979). This effect is not a
general suppression of all courtship activity, because trained
males do not modify their courtship of other pheromonally dis-
tinct targets (Ejima et al., 2005; Siwicki et al., 2005). After training
with a mated female, memory is measured as a decrease in CI
toward virgin females in trained males relative to naive controls.
InDrosophila, five phases of memory have been elucidated by
a combination of genetic and pharmacological dissection. There
is an immediate recall memory (immediate memory) at 0–2 min
after training, short-term memory out to 1 h, medium-term
Figure 1. The behavior of young adult (5-d-old) and elderly adult (45-d-old)wild-type flies (OreR).A–E, Naive courtship, learning during training, and short-termmemorywere examined inWT
flies at 5 and 45 d of age. Mean SEM CIs are plotted; n values are indicated above each bar for all groups. The levels of significance are indicated (*p 0.05, **p 0.01, ***p 0.001).WT flies
are OreR.A, Naive courtship in 5-d-oldWT (black bar) and 45-d-oldWT (open bar) flies.B, Learning during training in 5-d-oldWT flies. C, Learning during training in 45-d-oldWT flies.D, Short-term
memory in 5-d-oldWT flies. E, Short-termmemory in 45-d-oldWT flies. Thus, at 45 d of age, there is no significant change in naive courtship behavior or cognition inWT flies. The behavior of young
adult (5-d-old) psn-het flies. F–L, Naive courtship, learning during training, immediate recall, and short-termmemorywere examined in psn-het flies at 5 d of age. Psn-hetmales for the psn alleles
psn B3, psn C4, psn I2, psn K2, psn S3, psn C1, psn C2.1, psn EMS46, psn L(3)15, and psn L(3)14 were aged for 5 d after eclosion. psn-het males were tested for naive courtship (F ), learning during
training (G,H ), immediate recall (0–2minafter training) (I, J ), and short-termmemory (60minafter training) (K, L). Nodeficits in behavior or cognitive capabilitiesweredetected in anyof the tests
performed on the young adult psn-het flies.
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memory out to 6 h, anesthesia-resistant memory out to 2 d, and
long-termmemory lasting up to 9 d after training that appears to
be dependent on protein synthesis (Skoulakis and Gramme-
noudi, 2006). Intact short-term memory is dependent on intact
immediate recall. However, immediate recall and short-term
memory are distinct from LDT. Therefore, intact memory can
occur without LDT, and learning during training can occur with-
out posttraining memory (Joiner and Griffith, 1997; Kane et al.,
1997; McBride et al., 2005).
To assess LDT, a male fly was placed in a training chamber
with a previously mated female for 1 h, and the amount of time
the male spent courting in the initial 10 min interval was com-
paredwith the time spent engaged in courtship in the final 10min
interval. Normal LDT in 5-d-old WT flies is illustrated by a sig-
nificant 40% decrease in courtship during the training (Fig.
1B), and short-termmemory is illustrated in 5-d-oldWT flies by
a significant decrease in courtship toward virgin females 1 h after
training (Fig. 1D).We found that 45-d-oldWT flies also demon-
strated intact LDT and short-term memory (Fig. 1C,E). These
studies indicate that the courtship-based learning and memory
paradigm can be used to study aging-related issues of cognition
and behavior in flies.
Naive courtship, LDT, andmemory in young and aged adult
psn-het flies
Courtship was robust in naive males of all 10 psn-het genotypes
examinedas youngadults at 5dof age (Fig. 1F).Naivemalesof these
psn-het genotypes also displayed the normal steps of courtship be-
havior and normal levels of locomotor activity (supplemental Figs.
S3, S4, available at www.jneurosci.org as supplemental material).
LDT at 5 d of age in all 10 psn-het genotypes was normal, as
evidenced by decreases of40% from initial CI to final CI during
training with mated females (Fig. 1G,H). To examine the imme-
diate recall memory at 5 d of age, we took males that had just
completed a 1 h training session with a previously mated female
and immediately placed them in a new chamber with a virgin
target female for a 10 min courtship assay. This CI was then
compared with the courtship level of naive males that had been
placed in a training chamber for 1 h with no female, before being
introduced to a virgin target female. Immediate recall was intact
in all 10 psn-het genotypes examined (Fig. 1 I, J). To assay short-
termmemory, the trained male was placed in a holding chamber
for 60 min and then subsequently placed in a testing chamber
with a virgin female target. Nine of the psn-het genotypes were
tested and found to have normal short-termmemory at 5 d of age
(Fig. 1K,L).
We next examined naive courtship and LDT in 30-d-old (late
middle age) psn-het males. No significant effect on the level of
naive courtship (Fig. 2A), its quality (supplemental Fig. S5, avail-
able at www.jneurosci.org as supplemental material), locomotor
activity (supplemental Fig. S6, available at www.jneurosci.org as
supplemental material), or phototaxis or chemotaxis (data not
shown) was observed. However, males of all 10 different psn-het
genotypes failed to demonstrate the typical decrease in courtship
activity in LDT at 30 d of age (Fig. 2B,C). Impaired LDT is a very
rare phenotype in Drosophila but has been seen previously in
young adult flies that have altered calcium/calmodulin-
dependent kinase II or protein kinase C (PKC) expression or
activity (Joiner and Griffith, 1997; Kane et al., 1997). These re-
Figure 2. Naive courtship, LDT, immediate recall, and short-termmemory in 30-d-old (latemiddle aged) psn-het flies. psn-hetmales for the psn alleles psn B3, psn C4, psn I2, psn K2, psn S3, psn
C1, psn C2.1, psn EMS46, psn L(3)15, and psn L(3)14were aged for 30 d after eclosion. Mean SEM CIs are plotted. n values are indicated above each bar for all groups. The levels of significance are
indicated (**p 0.01, ***p 0.001).A, Naive courtship levels remained robust and only slightly reduced from5-d-old psn-het flies (comparewith Fig. 1 F) in all psn-hetmales.B, C, psn-hetmales
were tested for learning during training, and none of the psn-hetmales demonstrated at least a 40% reduction in courtship activity during the training session or a statistically significant reduction
in courtship behavior. Therefore, psn-het flies have an age-dependent impairment in learning during training. D, E, Immediate recall remained intact in all psn-het males. F, G, psn-hets were also
tested for short-termmemory at 60 min after training. All lines failed to exhibit short-termmemory, in contrast to their behavior at 5 d of age (Fig. 1 K, L).
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sults demonstrate an age-dependent impairment in LDT in psn-
het male flies by 30 d of age.
We next examined immediate recall and short-term memory
in the psn-het flies at 30 d of age. We found that males of all 10
different psn-het genotypes displayed intact immediate recall at
30 d of age (Fig. 2D,E). Intact immediate recall of courtship
memorywithout intact LDThas been observed previously in young
adult Drosophila (Joiner and Griffith, 1997; Kane et al., 1997). Al-
though immediate recall was intact, examination of short-term
memory in nine of the heterozygousmutant presenilin lines, at 30 d
of age, revealed that this form of memory was no longer intact (Fig.
2F,G). This is in contrast to 5-d-old psn-het and 45-d-oldWT flies,
which exhibited intact short-termmemory. This demonstrates that
there is an age-dependent impairment of short-term memory in
heterozygous psn loss-of-function flies.
Genetic interaction between psn and dfmr1
In an effort to identify novel pathways affected as a result of the
reduction in psn levels, we looked for genetic interactions be-
tween psn and other genes known to affect cognition and behav-
ior that might play a role in presenilin signaling based on the
literature. Interestingly, we identified a strong genetic interaction
between psn and theDrosophila fragile Xmental retardation gene
dfmr1. At 5 d of age, psn and dfmr1 heterozygous single-mutant
flies display normal naive courtship levels relative to their given
genetic background (supplemental Fig. S7, available at www.
jneurosci.org as supplemental material). However, 5-d-old flies
that are transheterozygousmutant for both psn and dfmr1 display
a severe reduction in naive courtship levels, which is rescued by
the introduction of onewild-type copy of a dfmr1 genomic rescue
construct. Such heterozygous synergistic genetic interactions are
rare and suggest that both genes act in one or more common
pathways important for normal naive courtship activity.
Prevention of age-dependent LDT and short-termmemory
deficits with pharmacological treatment
To explore the possibility of pharmacologically rescuing some
of the age-dependent psn-het phenotypes and in light of the
genetic interaction between psn and dfmr1 described above,
we focused on treatments that rescue naive courtship and cog-
nitive deficits in dfmr1mutants. One pathway that is known to
be affected in both fly and mouse models of fragile X is mGluR
signaling (Huber et al., 2002; McBride et al., 2005; Yan et al.,
2005; Do¨len et al., 2007; Bolduc et al., 2008). In previous
studies, we found that several of the phenotypes displayed by
the dfmr1 mutants, including naive courtship and memory,
could be rescued by treatment with antagonists of DmGluRA
and LiCl (McBride et al., 2005). More recent studies have also
observed this and have also found that similar rescue is ob-
tained by genetic reduction of DmGluRA activity, the sole
Drosophila mGluR (Bolduc et al., 2008; Pan et al., 2008).
Our working model is that treatment of flies with both
lithium and antagonists of DmGluRA will increase cAMP sig-
naling andmay also decrease InsP3R-mediated calcium release
(Fig. 3A). Lithium inhibits GSK-3 activity by competing with
the magnesium-binding site and increasing phosphorylation
at serine 9 (Gould and Manji, 2005; Huang and Klein, 2006;
Jope and Roh, 2006). There is an antagonistic relationship be-
tween protein kinase A (PKA) andGSK-3; therefore, this acts to
upregulate the downstream effect of cAMP signaling because
GSK-3 can inhibit cAMP response element-binding protein
(CREB)-mediated gene transcription (Bullock and Habener,
1998; Grimes and Jope, 2001; Mai et al., 2002; Tanji et al., 2002;
Hansen et al., 2004; Gould andManji, 2005). Lithium also inhib-
its inositol polyphosphate 1-phosphatase (IPPase) (Acharya et
al., 1998) and inositol monophosphatase (IMPase) (Berridge,
1993), thereby reducing the pool of InsP3 available to stimulate
InsP3R-mediated calcium signaling (Berridge, 1993; Takei et al.,
1998; Williams et al., 2002). Previous heterologous cell-based
studies have shown that DmGluRA can couple to heterotrimeric
Gi, leading to decreases in cAMP levels (Parmentier et al., 1996).
More recent in vivo studies have shown that DmGluRA also has
properties typically found associated with Gq-coupled group I
mGluRs such as regulating synaptic morphology and AMPA re-
ceptor presentation (Bogdanik et al., 2004; Pan and Broadie,
2007; Pan et al., 2008). Thus, antagonizing DmGluRA activity
will increase cAMP levels (by relieving inhibition of cAMP after
synaptic stimulation) and will possibly decrease InsP3R-me-
diated calcium signaling (Fig. 3A) (McBride et al., 2005). We
therefore explored the possibility that the age-dependent cogni-
tive deficits could be rescued by treatment withDmGluRA antag-
onists as well as lithium.
For this experiment, we used the competitive group II antag-
onist LY341495 [(2S)-2-amino-2-[(1S,2S)-2-carboxycycloprop-
1-yl]-3-(xanth-9-yl) propanoic acid] and noncompetitive mGluR5
antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP), aswell as
lithium at concentrations found previously to be optimal for
treating dfmr1mutants (McBride et al., 2005). LY341495 is a very
specific group II antagonist that has been shown to antagonize
DmGluRA in the nanomolar range (Bogdanik et al., 2004). Al-
though MPEP was developed as a noncompetitive antagonist of
the vertebrate group ImGluR5, we have included it in our studies
because the MPEP binding pocket of mGluR5 is more highly
conserved with DmGluRA than any other vertebrate mGluRs
and in previous experiments has similar activity to the known
DmGluRA antagonists LY341495,MPPG [(RS)--methylserine-
O-phosphate], and MTPG [(RS)--methyl-4-tetrazolylphenyl-
glycine] and shows similar effects to that obtained by genetically
reducing DmGluRA activity (Parmentier et al., 1996; Pagano et
al., 2000; Malherbe et al., 2003; Bogdanik et al., 2004; McBride et
al., 2005; Bolduc et al., 2008; Pan et al., 2008). However, because
it has not been formally shown to be an antagonist of DmGluRA,
it is therefore a putative DmGluRA antagonist.
Two different psn-het genotypes ( psn B3 and psn I2) were
treated with different drugs or non-drug-containing control ve-
hicle solutions from days 6 to 29 of adulthood (after eclosion).
Flies were then transferred to control food containing no drug for
1 d before being tested. Flies were treated with 5 mM NaCl (ionic
control for LiCl), 0.004% DMSO (the vehicle for LY341495), 5
mM LiCl (lithium), 8.6MMPEP, or 400 nM LY341495. Remark-
ably, treatment with LiCl, LY341495, or MPEP improved LDT
performance in psn-het flies (Fig. 3H–J). In contrast, no im-
provement was observed in flies treated with NaCl or DMSO
(Fig. 3K,L). These experiments demonstrate that the impairment
in LDT exhibited by the untreated psn-het flies can be prevented
by treatment with lithium, LY341495, and MPEP.
This result with LDT raised the possibility that treatment with
lithium, LY341495, and MPEP might also prevent the age-
dependent impairment in short-term memory that is exhibited
by the psn-het males. Using the same set of pharmacologic treat-
ments, we found that psn-het flies treated from 6 to 29 d after
eclosion with 5 mM lithium, 8.6 M MPEP, or 400 nM LY341495
demonstrated intact short-term memory (Fig. 3M–O), whereas
those treated with 5 mM NaCl or 0.004% DMSO did not (Fig.
3P,Q). This result demonstrates that the impairment in short-
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term memory exhibited by 30-d-old psn-het flies can be pre-
vented by treatments aimed at reducing DmGluRA activity. In
contrast, prolonged treatment of OreR (WT) flies with lithium,
LY341495, and MPEP impaired LDT and short-term memory,
whereas vehicle treatment did not (Fig. 3B–G).
The rescue that we observe when psn-hets are treated with
LY341495, MPEP, or lithium is analogous to the results, we ob-
tained when we treated dfmr1 mutants with these same drugs
(McBride et al., 2005). The similarity of these results suggests that
both psn-hets and dfmr1 mutants display cognitive deficits that
are attributable to enhanced DmGluRA signaling. However, an-
other possibility is that these drug treatments represent some type
of panacea that can rescue any cognitive deficit observed in flies.
With this second possibility in mind, we tested the effect of treat-
ing another disease model that displays age-onset loss of short-
term memory with LY341495, MPEP, and lithium.
We have found that expression of human wild-type -syn-
uclein in the mushroom bodies of the fly leads to age-dependent
loss of short-term memory. The mushroom bodies are required
for short-term memory formation in the conditioned courtship
paradigm (Joiner and Griffith, 1999; McBride et al., 1999). In
controls for these flies, short-term memory is intact at 30 d of
age (supplemental Fig. S8A, available at www.jneurosci.org as
supplemental material). In flies expressing human wild-type
-synuclein in the mushroom bodies, short-term memory is
intact at 5 d of age but is impaired at 30 d of age (supplemental
Fig. S8B, available at www.jneurosci.org as supplemental ma-
terial). Treatment of these flies with lithium, LY341495, or
MPEP failed to rescue this deficit (supplemental Fig. S8C,D,
available at www.jneurosci.org as supplemental material), in-
dicating that rescue of cognitive deficits in the psn-hets by the
drug treatments is disease specific and may not necessarily be
extrapolated to other disease models displaying age-dependent
cognitive impairments.
Morphological analysis of heterozygous psn brain tissues
The age-dependent impairments in LDT and short-term mem-
ory observed in the psn-het flies could possibly be attributable to
the loss of critical neurons as a result of cell death. There is a body
of literature describing loss of synapses and neurons in the brains
of Alzheimer’s patients and in related mouse models (Selkoe,
2002;Mattson, 2004;Walsh and Selkoe, 2004;Hardy, 2006; Small
and Gandy, 2006). To determine whether neuronal loss could
account for the cognitive loss, we performed TUNEL staining on
Figure3. Pharmacologic treatmentsprevent impairments in learningduring trainingand short-termmemory inpsn-het flies at 30dof age.A, Adiagramof theputative signaling inourADmodel
as well as that from the literature is shown. Arrows indicate activation or increases, and blunt ends indicate inhibition or decreases in activity or protein levels. The double line between wild-type
presenilin and InsP3R indicates an interaction that is neutral or inhibitory. Previous studies have established that group ImGluRs inmammals activate theGqpathway,whereas thegroup II andgroup
III mGluRs activate the Gi signaling pathway. However, there is accumulating evidence that, in mammals, group II mGluRs may activate the Gq signaling pathway and induce long-term depression
in a manner dependent on phospholipase C (PLC) and InsP3R activity (Huang et al., 1997, 1999a,b; Otani et al., 1999, 2002), and group I mGluRs are capable of activating Gi (Kreibich et al., 2004).
We are outlining in thismodel the actions of DmGluRA inDrosophila, which is known to activate Gi activity, and recent studies indicate that itmay also activate Gq activity, just as is the case of group
II mGluRs inmammals (Pan et al., 2008). During activation, Gq activates PLC, which produces DAG and InsP3. DAG and InsP3 can activate PKC and the InsP3R to release calcium from the endoplasmic
reticulum. Gi activation inhibits adenylate cyclase, thereby preventing an increase in cAMP in response to synaptic stimulation, which prevents the activation of CREB by PKA. Phosphodiesterase
4 (PDE4) breaks down cAMP levels.MPEP is a group ImGluR5 noncompetitive antagonist, whichwe use at high concentrations to block DmGluRA. LY341495 is a very specific competitive antagonist
of DmGluRA (Bogdanik et al., 2004). LiCl has two main actions at therapeutic levels in cells, one of which is the lowering of InsP3 levels by inhibiting inositol monophosphatase and inositol
polyphosphatase, thereby decreasing the synthesis of InsP3, as well decreasing the rate at which it is recycled (Berridge, 1993; Takei et al., 1998; Williams et al., 2002). The second action of lithium
is the inhibition of GSK-3 activity (Klein andMelton, 1996). It is through the aforementioned activities thatwepropose that these drugsmay alter signaling in theDrosophilabrain.B–G, Treatment
ofWT control flies (OreR)with the DmGluRA antagonist LY341495, the putative DmGluRA antagonistMPEP, or lithiumduring aging results in impairment of learning during training and short-term
memory. WT control flies were raised on control food and then, after day 6 after eclosion, were placed on food containing either 8.6MMPEP (MP) or vehicle (Veh) (B, E), 400 nM LY341495 (LY) or
vehicle (Veh) (C, F ), or 5.0mM lithium (Li) or 5.0mMNaCl (Na) (D,G) until day 29 and thenwere tested on day 30.H–Q, Treatment of psn-hetswith the DmGluRA antagonist LY341495, the putative
DmGluRA antagonist MPEP, or lithium prevents the age-dependent impairments in learning during training and short-term memory observed in psn-het flies. psn-hets for the psn B3 and psn I2
alleleswere raised on control food and then, at day 6 after eclosion,were placed on food containing 8.6MMPEP (H,M ), 400nM LY341495 (I,N ), 5.0mM lithium (J,O), 5.0mMNaCl (K,P), or 0.004%
DMSO (L,Q) until day 29.Mean SEMCIs are plotted. n values are indicated above each bar for all groups. The levels of significance are indicated (*p 0.05, **p 0.01, ***p 0.001). A triangle
indicates a 40% or greater reduction in courtship activity during the training session with a previously mated female (H–L). OreR flies that were treated with MPEP, LY341495, and lithium lacked
detectable learning during training (B–D) or short-term memory (E–G). OreR flies treated with DMSO or NaCl displayed normal learning during training (B–D) and short term memory (E–G).
psn-het flies that were treated with LY341495, MPEP, or lithium demonstrated intact learning during training (H–J ) and intact short-termmemory (M–O) at 30 d of age. In contrast, psn-het flies
that were on food containing NaCl or DMSO did not display learning during training (K, L) or short-termmemory (P, Q) at 30 d of age.
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aged psn-het and control flies. Additionally, we examined the
morphology of the MBs in aged psn-het brains, which are re-
quired for short-termmemory in the conditioned courtship par-
adigm (Joiner and Griffith, 1999; McBride et al., 1999). In the
brains of 50-d-old psn-het and OreR flies, we failed to detect any
consistent neuronal loss by TUNEL staining or any gross defects
in MBmorphology, indicating that the observed cognitive loss is
most likely not attributable to an age-dependent loss of neurons
or breakdown in MB integrity (Fig. 4A–F). Consistent cell death
was observed in 5-d-old (positive control) Adar mutant brains,
which have been shown previously to undergo neuronal cell loss
(Fig. 4C,D) (Palladino et al., 2000).
Reversal of the learning during training and short-term
memory impairments
Because the brain tissue of the aged psn-het flies appears to be
morphologically normal, we considered the possibility that the
age-related behavioral phenotypes could be reversed after they
have already become established. Because the age-dependent im-
pairments in LDT and short-termmemory could be prevented by
treatment with LY341495, MPEP, or lithium, we next examined
whether these phenotypes could be reversed by these treatments.
Reversal of the deficits would further indicate that the age-
dependent cognitive impairments were likely the result of phys-
iological neuronal defects (disrupted intracellular signaling
possibly followed by synapse loss) and not cell death. Using the
same two genotypes ( psn-hets with decreased presenilin activity)
that were subjected to treatments as young adults (Fig. 3), we now
began treatments at day 30 and treated until day 44, testing at 45 d
of age. As above, flies were treated with 5 mM NaCl, 0.004%
DMSO, 5mM lithium, 8.6MMPEP, or 400 nMLY341495. Treat-
ment with LY341495 and the putative DmGluRA antagonist
MPEP, as well as lithium, reversed the LDT (Fig. 4G–I) and
short-termmemory (Fig. 4L–N) phenotypes in both lines tested.
In contrast, treatment with 5 mM NaCl and the DMSO vehicle
from days 30 to 44 failed to restore normal LDT (Fig. 4 J,K) or
short-term memory (Fig. 4O,P) in either of the two lines. This
demonstrates that the impairments in LDTand short-termmem-
ory exhibited by untreated psn-het flies can be reversed by treat-
ments aimed at reducing DmGluRA activity. This finding is
significant considering that our results may be relevant to the
pathogenesis of Alzheimer’s disease in humans, which is only
Figure 4. Cell death and morphology in 50-d-old psn-het flies. Pharmacologic treatments can reverse impairments in learning during training and short-term memory in psn-het flies. A–C,
Analysis of cell death in agedpsn-het, OreR, andAdarmutant brains. TUNEL stainingwasperformedon50-d-old (negative control) OreR (A), 50-d-oldpsn-het (B), and5-d-old (positive control)Adar
mutant brains (C). The brains were examined by confocal microscopy to identify cells undergoing cell death. Foci containing at least one cell undergoing cell death are denoted by white arrows.
Maximum projections, as shown in A–C, made from confocal stacks of entire brains were examined for cell death foci. The number of foci in the central brain region for each brain was scored. The
distribution of the number of cell death foci versus the percentage of brains with such number of foci is shown inD. Themajority of psn-het brains lacked any detectable cell death (n 41). Those
that did had less than five foci, and there was no consistent location in the brain in which the foci were detected. Similar results were obtained with the OreR brains (n 33). Cell death foci were
detected in allAdarmutant brains (n5),whichhavebeendescribedpreviously toundergomassive cell loss via cell death (Palladino et al., 2000). Fifty-day-oldOreR (E) andpsn-het (F ) brainswere
stained with anti-FasII and examined by confocal microscopy to examine the integrity of the mushroom bodies. This antibody strongly labels the -lobes (white arrow with *, shown in E) and
-lobes (arrowhead shown inE) andweakly stains the-lobes (white arrowwith #, shown inE). Therewas nodetectable difference in themorphology of themushroombodies betweenOreR (n
21) andpsn-het (n18) brains.G–P, Treatmentwith LY341495,MPEP, or lithium reverses the age-dependent impairments in learningduring training and short-termmemory observed inpsn-het
flies. psn-hets for the psn B3 and psn I2 alleles were raised on control food and then, at day 30 after eclosion, were placed on food containing 8.6MMPEP (G, L), 400 nM LY341495 (H,M ), 5.0 mM
lithium (I, N ), 5.0 mM NaCl (J, O), or 0.004% DMSO (K, P) until day 44 and were tested on day 45. Mean SEM CIs are plotted, and n values are indicated above each bar for all groups. The levels
of significance are indicated (**p 0.01, ***p 0.001). A triangle indicates a 40% or greater reduction in courtship activity during the training session with a previously mated female (G–P).
psn-het flies that were treated with LY341495, MPEP, or lithium demonstrated intact learning during training (G–I ) and intact short-termmemory (L–N ) at 45 d of age. In contrast, psn-het flies
that were on food containing NaCl or DMSO did not display learning during training (J, K ) or short-termmemory (O, P) at 45 d of age.
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recognized after the onset of cognitive impairments, emphasizing
the need to develop therapeutic strategies that can be imple-
mented after the appearance of overt disease symptoms.
Genetic reductionofDmGluRAprevents the onset of LDT and
short-termmemory defects in aged psn-hets
To validate the pharmacological studies described above, we
tested the effect of genetically reducing the level ofDmGluRA, the
only metabotropic glutamate receptor in the Drosophila genome
(Bogdanik et al., 2004), in the psn-het background. Given the
reported binding specificities of MPEP, the ability of MPEP
treatment to phenocopy genetic loss of function in DmGluRA
mutants, the reported actions of lithium, and the fact that
LY341495 has been shown to be a very efficient antagonist of
DmGluRA, our drug treatments should reduce DmGluRA sig-
naling activity (Bogdanik et al., 2004;McBride et al., 2005). If our
observed rescue is occurring through reduction of DmGluRA
signaling activity, our expectation is that genetic reduction of
DmGluRA should similarly provide some level of rescue of the
age-onset cognitive deficits. To perform this test, we used the
previously described null allele of DmGluRA (DmGluRA112)
and precise excision wild-type allele (DmGluRA2b) (Bogdanik
et al., 2004).
In testing DmGluRA heterozygous flies alone, we found that,
at 30 d of age, they display a defect in LDT as well as in short-term
memory (Fig. 5A,D), which is similar to what we observed when
OreR control flies were treated with LY341495, MPEP, and LiCl
(Fig. 3B–G). In contrast, the wild-type controls for these lines
displayed intact LDT and short-termmemory at 30 d of age (Fig.
5A,D). Consistent with our hypothesis, we find that reducing the
gene dosage of the DmGluRA receptor by 50% in the psn-het
background prevents the age-onset loss of LDT and short-term
memory observed previously at 30 d of age, whereas introduction
of the precise excision allele has no effect (Fig. 5B,C,E,F). These
results validate the pharmacological studies described above and
again indicate that enhanced DmGluRA signaling contributes to
the age-onset cognitive deficits. The re-
sults obtained from the DmGluRA het-
erozygous flies and OreRWT flies treated
with MPEP, LY341495, and lithium, as
described above, all indicate that LDT and
short-term memory are sensitive to a re-
duction in the activity of this receptor as
well.
Genetic reduction of the inositol
polyphosphate 1-phosphatase prevents
age-onset cognitive defects in the
psn-hets
The results of our pharmacological and
genetic analysis indicate that reducing
DmGluRA signaling rescues age-onset
cognitive deficits in psn-hets. Activation
of DmGluRA through the Gi-coupled
pathway lowers cAMP signaling and
through potential Gq coupling should in-
crease InsP3R-mediated calcium signaling
(Fig. 3A) (McBride et al., 2005). Lithium
as well as DmGluRA antagonists should
act to increase cAMP-mediated signaling
by increasing PKA activity and may also
act to lower InsP3R-mediated calcium sig-
naling (Fig. 3A).
Previous studies indicate that presenilin proteins bind to the
inositol triphosphate receptor, and expression of mutant forms
of presenilin protein lead to elevated Ca2 signaling (Stutzmann
et al., 2004; Cheung et al., 2008). The mechanism linking mGluR
activity to increased InsP3R activity is shown in Figure 3A. De-
creased presenilin function by FADmutations has been shown to
increase the sensitivity of the InsP3R to InsP3. This means that, in
response to glutamate release after synaptic stimulation, the
mGluR will be activated, thereby activating Gq and Gi. The Gq
activation will in turn generate InsP3. Because there is less wild-
type presenilin present to basally inhibit the sensitivity of the
InsP3R to InsP3, there will be enhanced InsP3R-mediated calcium
release in response to physiologic synaptic stimulation. To test
whether the rescue we observe with genetic and pharmacological
manipulation aimed at reducing DmGluRA activity is possibly
working by lowering enhanced InsP3R activity, we have under-
taken manipulations to directly lower InsP3R activity. Toward
this goal, we tested the effect of genetically reducing the levels of
the IPPase locus. IPPase as well as IMPase are directly inhibited
by lithium and are required for InsP3 recycling and synthesis
(Berridge, 1993). Genetic reduction of IPPase has been shown to
reduce InsP3R signaling in flies (Acharya et al., 1998). We tested
two loss-of-function alleles (IPPase1 and IPPase3) (Acharya et al.,
1998) as heterozygotes and found that, at 30 d of age, heterozy-
gous males for one allele (IPPase1) lacked significant LDT, but
heterozygote males for both alleles displayed normal short-term
memory (Fig. 6A,D). When crossed in the psn-het backgrounds,
the IPPase3 allele prevented loss of LDT in both psn alleles and the
IPPase1 allele prevented this loss of LDT in the psnB3-het back-
ground (Fig. 6B,C). Both alleles of IPPaseprevented loss of short-
term memory in both psn-het lines (Fig. 6E,F). These results
indicate that reduction of IPPase activity can prevent the age-
onset cognitive deficits observed with the psn-het flies. Next we
directly tested whether genetic reduction of the InsP3R gene itself
could modulate the age-dependent psn-het phenotypes. To test
the effect of genetically reducing InsP3R activity, we used three
Figure5. Agenetic reduction ofDmGluRA rescues short-termmemory in psn-het flies at 30 d of age. All flieswere tested at 30 d
of age for learning during training or short-termmemory. Mean SEM CIs are plotted, and n values are indicated above each bar
for all groups. The levels of significance are indicated (*p0.05, **p0.01, ***p0.001). A triangle indicates a 40%or greater
reduction in courtship activity during the training session with a previously mated female (A–C). DmGluRA112 is a null allele and
DmGluRA2b is a precise excision wild-type control allele of DmGluRA. A, Heterozygosity for the DmGluRA null impairs learning
during training. Heterozygosity ofDmGluRA rescues learning during training in psn-het B3 (B) and psn-het I2 (C) flies.D, Heterozy-
gosity for the DmGluRA null impairs short-termmemory. E, F, Heterozygosity of DmGluRA rescues short-termmemory in psn-het
B3 (E) and psn-het I2 (F ) flies.
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different strength alleles: a hypomorph
(wc361), a molecular null (90B0), and an
antimorphic allele (wc703) (Venkatesh
and Hasan, 1997; Deshpande et al., 2000).
At 30 d of age, heterozygous males for
these alleles display weak (wc703) or no
detectable (wc361 and 90B0) LDT, and all
display normal short-term memory (Fig.
7A,E). When introduced into the psn-het
background, two of these alleles pre-
vented loss of LDT in the B3 allele of psn
(Fig. 7B–D), and all three alleles prevent
the loss of short-termmemory in both psn
alleles at 30 d of age (Fig. 7F–H). The 90B0
allele continues to prevent this loss of
short-term memory at 40 d of age (Fig.
7I). These results suggest that a reduction
in InsP3R-mediated Ca
2 release is also
another potential route to ameliorate the
age-onset cognitive deficits associated
with reduced psn levels.
Discussion
To date, all cases of early onset familial
forms of Alzheimer’s disease are attribut-
able to mutations in a single copy of PS1,
PS2, or APP. The large number of differ-
ent mutations in the PS1 and PS2 genes
that cause AD as well as analysis of the
protease function of FAD mutants is consistent with a loss of
function of PS1 and PS2 as a contributing cause of FAD (De
Strooper, 2007; Hardy, 2007; Shen and Kelleher, 2007). This in-
terpretation of the data suggests that the levels or activity of PS1,
PS2, and APP are crucial for maintaining normal cognition
throughout life. Based on these studies, we have explored
whether this dosage sensitivity of presenilin also exists in Dro-
sophila by examining the cognitive capabilities of psn-het flies in
young and progressively aged psn-het flies. Using a conditioned
courtship paradigm, we have found that deficits in LDT and
short-term memory develop in the psn-het flies with age. These
results further strengthen the hypothesis that some aspects of
FAD and possibly AD may be caused by reduced levels of psn
activity.
The appearance of cognitive deficits before any detectable
neuronal loss
Previous Drosophila AD models have revealed phenotypes that
have parallels with those observed in mouse models and human
patients. These fly models have been based on ectopic expression
of either human tau or human A40 or A42 peptides and have
been shown to exhibit either hyperphosphorylated tau or aggre-
gations of A that result in neurodegeneration (Wittmann et al.,
2001; Iijima et al., 2004; Mershin et al., 2004; Crowther et al.,
2005). Additionally, it has been demonstrated that expression of
human tau, A40, or A42 leads to memory deficits (Iijima et al.,
2004; Mershin et al., 2004). In these models, memory deficits are
already present in young adult flies. In contrast, we have uncov-
ered cognitive impairments that are age dependent in the psn-het
flies and occur before any detectable loss of neurons. In studying
the psn-het flies, we detect a clear deficit in LDT and short-term
memory that appeared by 30 d of age. Our examination for cell
death was done on psn-hets that were at least 50 d old, e.g., 20 d
older than when the defects in LDT and short-term memory are
detected. Consistent with this finding, we were able to reverse the
cognitive deficits by initiating treatment at day 30, which would
likely not occur if neuronal loss were the cause of the cognitive
decline.
Although neuronal death is typical of AD, cognitive impair-
ment precedes neuronal death in humans and animal models.
Indeed, recent studies have indicated that synapse loss is better
correlated with memory impairment than the histopathological
hallmarks of plaques and tangles in AD patients (DeKosky and
Scheff, 1990; Terry et al., 1991; Coleman and Yao, 2003). In fact,
memory impairment in Alzheimer’s disease can occur in the ab-
sence of plaques and tangles in animal models (Oddo et al., 2003;
Gong et al., 2004; Iijima et al., 2004; Mershin et al., 2004; Billings
et al., 2005) or in FAD patients (Raux et al., 2000; Amtul et al.,
2002; Dermaut et al., 2004; Halliday et al., 2005). Additionally,
within 2–4 years of AD onset, 25–35% loss of synapses is ob-
served in biopsies of frontal cortex in afflicted patients (Davies et
al., 1987). Furthermore, synaptic function may be impaired even
before synaptic loss occurs in animal models of AD as well as in
patients (Oddo et al., 2003; Palop et al., 2003; Westphalen et al.,
2003; Yao et al., 2003). Thus, our results add to a growing body of
literature that indicates that loss of synaptic plasticity can occur
before or without plaque or tangle formation or neuronal loss.
Our results also demonstrate that this loss of synaptic plasticity
can occur solely as a result of a reduction in psn activity, in the
absence of A accumulation, which does not occur inDrosophila.
Pharmacological rescue of LDT and short-term memory
In a genetic search for pathways affected by a reduction in psn
levels, we identified a strong genetic interaction between psn and
dfmr1. Because this genetic interaction revealed a phenotype in
courtship that was rescued previously in dfmr1 mutant flies by
treatment with DmGluRA antagonists and lithium, we explored
the possibility that these drugs might have efficacy in treating the
Figure 6. A reduction in IPPase expression rescues short-termmemory in psn-het flies at 30 d of age. All flies were tested
at 30 d of age for learning during training or short-term memory. Mean SEM CIs are plotted, and n values are indicated
above each bar for all groups. The levels of significance are indicated (***p 0.001). A triangle indicates a 40% or greater
reduction in courtship activity during the training session with a previously mated female (A–C). A, Heterozygosity for the
IPPase loss-of-function mutant IPPase 1 impairs learning during training, whereas heterozygosity for IPPase 3 does not. B,
Heterozygosity of the IPPase loss-of-function mutants rescues learning during training in psn-het B3. C, Heterozygosity for
the IPPase 3 loss-of-function mutant rescues learning during training in psn-het I2 flies, whereas heterozygosity for IPPase
1 does not. D, Heterozygosity for the IPPase loss-of-function mutants does not impair short-term memory. E, F, Heterozy-
gosity of the IPPase loss-of-function mutants rescues short-term memory in psn-het B3 (E) and psn-het I2 (F ) flies.
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age-onset phenotypes of the psn-hets. Consistent with our find-
ings, recent studies of mouse Alzheimer’s disease models and of
afflicted humans have suggested that calcium signaling is en-
hanced and cAMP signaling may be decreased (Selkoe, 2002;
Gong et al., 2004; Mattson, 2004; Walsh and Selkoe, 2004). We
propose that these two signaling pathways are downstream of
DmGluRA signaling (Fig. 3A).
In our studies, we demonstrated that treatment with lithium,
the DmGluRA antagonist LY341495, and the putative DmGluRA
antagonist MPEP prevented age-dependent impairments in psn-
het flies at 30 d of age and can reverse LDT and short-termmem-
ory impairments if treatment is begun at 30 d of age, a time point
after the deficits appear. These treatments should function to
counteract decreased cAMP signaling and may counteract in-
creased InsP3R-mediated calcium release (Fig. 3A).
The successful treatments of the psn-hets are consistent with
results from two studies in mouse models of AD, both of which
demonstrated improved cognition through pharmacological
treatment without effects on A plaque burden. First, Gong et al.
(2004) demonstrated that increasing cAMP levels can rescue be-
havioral plasticity, and second, Malm et al. (2007) showed that
indirectly inhibiting GSK-3 activity rescues behavioral plastic-
ity. The results from our studies demonstrate that treatment with
lithium, LY341495, or MPEP can rescue cognitive loss attribut-
able to reduced psn activity, a conditionwe propose exists in FAD
and possibly sporadic AD.We therefore suggest that lithium and
mGluR antagonists should be considered for additional study as
potential agents for therapeutic treatment of cognitive deficits
associated with Alzheimer’s disease.
Genetic reduction of the InsP3R pathway also prevents
age-onset cognitive decline
We wanted to further elucidate the pathways downstream of
DmGluRA that might be responsible for the rescue observed
when the DmGluRA activity is reduced, genetically or pharma-
cologically. Lithium treatment and decreases in mGluR activity
both lower InsP3R-mediated calcium signaling in vertebrates. In
our genetic tests, we found that genetic reduction of InsP3R-
mediated calcium signaling provides similar rescue to that ob-
served when DmGluRA activity is reduced genetically. By testing
multiple alleles of IPPase as well as InsP3R, we found that, in
general, loss-of-function mutants of both genes provided rescue
of age-onset deficits of LDT and short-term memory in the
psn-hets.
The InsP3R is an endoplasmic reticulum localized Ca
2 chan-
nel that releases Ca2 from the endoplasmic reticulum into the
cytoplasm in response to InsP3 binding. It was demonstrated
recently that FAD mutations of presenilin expressed in cells re-
sulted in increased sensitivity to InsP3-mediated Ca
2 release,
leading to enhanced cytoplasmic concentrations of Ca2
(Cheung et al., 2008). These results fit with previous studies in
which both FADmutations and loss of functional activity ofwild-
type presenilin have been linked to increases in InsP3R-mediated
calcium signaling in cell culture and transgenic mouse models of
AD (Peterson et al., 1988; Huang et al., 1991; Ito et al., 1994;
Tatebayashi et al., 1995; Hirashima et al., 1996; Etcheberrigaray et
al., 1998; Stutzmann et al., 2004). Our results demonstrating that
pharmacological treatment with drugs that should reduce Dm-
GluRA activity, as well as genetic reduction of DmGluRA, IPPase,
and the InsP3R are consistent with the hypothesis that reduction
in this Ca2 release mechanism might ameliorate the age-onset
cognitive deficits associated with AD. Moreover, these results
provide the first test of the pathogenic nature of enhanced
InsP3R-mediated calcium signaling in AD. Previous studies have
speculated on the pathogenic nature of this calcium signaling but
could not rule out the possibility that these changes were com-
pensatory in AD. Herein we were able to demonstrate a rescue of
Figure7. A reduction in InsP3Rexpression rescues short-termmemory inpsn-het flies at 30and40dof age.All flieswere testedat either 30or 40dof age for learningduring trainingor short-term
memory. Mean SEM CIs are plotted, and n values are indicated above each bar for all groups. The levels of significance are indicated (*p 0.05, ***p 0.001). A triangle indicates a 40% or
greater reduction in courtship activity during the training session with a previously mated female (A–D). A, Heterozygosity for the InsP3R loss-of-function mutants 361 and 90B0 impairs learning
during training, whereas heterozygosity for the InsP3R loss-of-functionmutant 703 does not completely abrogate learning during training.B, Heterozygosity of the InsP3R loss-of-functionmutants
703 and 361 rescues learning during training in psn-het B3 flies. C, Heterozygosity of the InsP3R loss-of-function mutants 703 and 361 fails to rescue learning during training in psn-het I2 flies. D,
Heterozygosity for the InsP3R loss-of-functionmutant 90B0 does not rescue learning during training in psn-het B3 or psn-het I2 flies. E, Heterozygosity for the InsP3R loss-of-functionmutants does
not impair short-termmemory. F, G, Heterozygosity of the InsP3R loss-of-function mutants 703 and 361 rescues short-termmemory in psn-het B3 (F ) and psn-het I2 (G) flies.H, I, Heterozygosity
of the InsP3R loss-of-function mutant 90B0 rescues short-termmemory in psn-het B3 and psn-het I2 flies at 30 d (H ) and 40 d (I ) of age.
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cognitive deficits by decreasing this signaling, indicating that up-
regulation of this pathway leads to cognitive loss over time.
In conclusion, our study ofDrosophila psn haploinsufficiency
contributes to the understanding of age-onset cognitive loss and
provides a newmodel to study aspects of Alzheimer’s disease.We
examined several phases of learning and memory in young and
older Drosophila adults and identified age-dependent cognitive
impairments in learning during training and short-term mem-
ory. We have demonstrated that lithium treatment can rescue
cognition in an animal model of AD. These results are in contrast
to a previous attempt with lithium treatment in a mouse
model of AD that failed to rescue working memory impair-
ments (Caccamo et al., 2007). We have additionally identified
and demonstrated the efficacy of mGluR antagonists as a novel
therapeutic target for the treatment of the cognitive deficits
associated with AD. Our results also indicate that lowering
IPPase activity or lowering InsP3R-mediated calcium signal-
ing can rescue cognitive loss. Finally, this study demonstrates
that reversal of memory impairment after onset can be ob-
tained by treatment with either mGluR antagonists or lithium.
These results suggest novel therapeutic targets that may have
relevance for treatment of AD to be explored in other animal
models.
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